In a multicenter randomized trial of treatment for benign prostatic hyperplasia (BPH), three methods for determining prostate size were used. Data on sequential measurements of prostate volume in patients taking a placebo were used to determine the variability in the techniques. Suprapubic ultrasound scanning with measurements in three dimensions demonstrated a coefficient of variation of 30 %. Prostate volume determined by transrectal ultrasound and three measurements had in a variability of 12%. Step-section planimetry offered the lowest variability, 5%, and should be the method of choice in determining prostate size in clinical studies of BPH.
No takes yet. Share an insight, caveat, or question.
Stone et al. (1991) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: